BioPharma Dive June 3, 2024
Treatment with the GLP-1 drug led to an average reduction in body weight of 6% over three months, although most study participants experienced nausea.
Dive Brief:
- An experimental GLP-1 pill helped people with obesity lose significantly more weight than a placebo over three months, according to summary results revealed by developer Structure Therapeutics Monday.
- In the Phase 2a study, which enrolled 64 healthy individuals who were obese or overweight, Structure’s drug led to an average reduction in body weight of 6.2% over placebo. One-third of those on the drug, dubbed GSBR-1290, lost 10% or more of their body weight, compared to zero of those given placebo.
- Shares in Structure soared by more than half on news of the data,...
Today's Sponsors
Today's Sponsor